University of Colorado- Anschutz Medical Campus
Welcome,         Profile    Billing    Logout  
 13 Trials 
16 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Anderson, Peter
NCT05140954: The Women TAF-FTC Benchmark Study

Completed
2/3
54
RoW
co-formulated 25mg TAF/ 200mg FTC, Descovy
University of Washington, Kenya Medical Research Institute, University of Colorado, Denver, Gilead Sciences
HIV Infections
12/23
12/23
Erlandson, Kristine
NCT04495348: Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance

Completed
N/A
18
US
Doravirine
University of Colorado, Denver, Gilead Sciences
HIV-1-infection, Weight Gain
01/23
06/23
Forman, Lisa
NCT01846663: Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

Terminated
4
6
US
Placebo, Rifaximin, XIFAXAN® Tablets
Bausch Health Americas, Inc.
Hepatic Encephalopathy
02/16
02/16
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
NCT05569759: A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

Active, not recruiting
2
24
US
zetomipzomib, KZR-616, placebo, sterile water for injection, zetomipzomib in open-label extension
Kezar Life Sciences, Inc.
Autoimmune Hepatitis
02/25
08/25
NCT06699121: A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Not yet recruiting
2
87
US
LB-P8 low-dose, LB-P8 high-dose, Placebo
LISCure Biosciences
Primary Sclerosing Cholangitis (PSC)
03/28
02/29
Boimbo, Sandra
NCT04404101: Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies

Recruiting
N/A
300
US
1). EUS-FNA plus MFB, 2). EUS-FNA Alone
University of Colorado, Denver, US Endoscopy
Pancreatic Cyst
04/25
04/25
Stites, Erik
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Active, not recruiting
N/A
4000
US
Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)
CareDx
Kidney Transplant Rejection
06/25
12/25
ProActive, NCT04091984: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry

Active, not recruiting
N/A
5000
US
Prospera
Natera, Inc., University of Maryland
Kidney Transplant Rejection
10/26
10/27
Kornfeld, Lisa
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Active, not recruiting
N/A
4000
US
Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)
CareDx
Kidney Transplant Rejection
06/25
12/25
Oser, Tamara K
NCT05168657: Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Completed
N/A
54
US
Bionic Pancreas, BP, Usual Care, UC
University of Colorado, Denver, Beta Bionics, Inc., Massachusetts General Hospital
Diabetes Mellitus, Type 1, Type 1 Diabetes, Diabetes, Autoimmune, Diabetes type1, Autoimmune Diabetes, Diabetes Mellitus, Brittle, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, 1, Diabetes Mellitus, Juvenile-Onset, Diabetes Mellitus, Ketosis-Prone, Diabetes Mellitus, Sudden-Onset, Insulin-Dependent Diabetes Mellitus 1, Juvenile-Onset Diabetes, Type 1 Diabetes Mellitus
05/23
05/23
IMPEDE, NCT05580978: CGM Plus GEM in Prediabetes

Completed
N/A
40
US
GEM, Routine Care
University of Colorado, Denver, Abbott Diabetes Care, University of Virginia
PreDiabetes
01/25
01/25
SECURE-T2D, NCT05815342: OP5-005 Using Omnipod 5 in Adults With Type 2

Completed
N/A
343
US
Omnipod 5 Automated Glucose Control System
Insulet Corporation, Jaeb Center for Health Research
Type2 Diabetes
03/24
03/24
GEM, NCT05766735: Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: a Paradigm Shift in Lifestyle Modification

Recruiting
N/A
200
US
Routine Care + Glycemic Excursion Minimization (RC+GEM), Glucose Everyday Matters, Routine Care (RC)
Chiara Fabris, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), DexCom, Inc.
Type 2 Diabetes
01/27
01/27
Prince, Britney
IMPEDE, NCT05580978: CGM Plus GEM in Prediabetes

Completed
N/A
40
US
GEM, Routine Care
University of Colorado, Denver, Abbott Diabetes Care, University of Virginia
PreDiabetes
01/25
01/25
GEM, NCT05766735: Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: a Paradigm Shift in Lifestyle Modification

Recruiting
N/A
200
US
Routine Care + Glycemic Excursion Minimization (RC+GEM), Glucose Everyday Matters, Routine Care (RC)
Chiara Fabris, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), DexCom, Inc.
Type 2 Diabetes
01/27
01/27
Steele, Cortney
No trials found

Download Options